About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ketorolac vs Oxycodone for Great Toe Arthrodesis | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 1NCT05054868

Ketorolac vs Oxycodone for Great Toe Arthrodesis

This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need for taking oxycodone (standard of care) for pain relief. The study also investigates if ketorolac affects ...

Lead sponsor: Medstar Health Research Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Amy Loveland

CONTACT

3015602937 amy.loveland@medstar.net

Crisanto Macaraeg

CONTACT

410-261-8218 crisanto.l.macaraeg@medstar.net

Sponsors

Lead Sponsor

Medstar Health Research Institute

This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need for taking oxycodone (standard of care) for pain relief. The study also investigates if ketorolac affects bone healing after surgery.

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18 - 75 years.
•Women of childbearing potential must have a negative serum or urine pregnancy test results within 24 hours before the first dose of ketorolac.
•Primary elective great toe MTP arthrodesis (CPT 28750). Other forefoot procedures often performed in conjunction with toe fusion will be included (CPT codes 28308, 28285, 28270).

Exclusion Criteria

•Chronic pain syndrome, CRPS or fibromyalgia
•Revision procedures
•Use of allograft bone at the fusion site
•Tobacco use
•Diabetes
•Narcotic abuse or IV drug abuse
•Any CPT codes involving the midfoot, hindfoot, and/or ankle
•Unable to take NSAIDs secondary to medical comorbidities such as kidney disease (impaired renal function with CrCl ≤ 50 ml/min) or gastric ulcers
•Weight \< 50 kg
•Does not speak or read English
•If pregnant or planning to become pregnant or breastfeeding
•Non-independent dweller (prisoner)

Related studies

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

NCT07225751 · Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, and more

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

NCT04715139 · Hyperpronated Foot, Reconstruction Surgeries of the Foot, and more

Registry of Arthrex Hand and Wrist Products

NCT05046600 · Ulnar/Radial Collateral Ligament Reconstruction, Ligament Repair or Reconstruction, and more

Enrolling By Invitation

Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells

NCT01409954 · Pseudarthrosis After Fusion or Arthrodesis

Active Not RecruitingNA

Lumbar Fusion With Porous Versus Non-Porous Cages

NCT05583864 · Spinal Fusion, Lumbar Fusion, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 12, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE1

Enrollment40

Start dateApr 2020

Last updatedJul 12, 2023

Condition

Locations shown

Amy Loveland

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions